09/29/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/29/2020. This three-page fact sheet informs healthcare providers of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Akron Children’s Hospital SARS-CoV-2 Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
No hay comentarios:
Publicar un comentario